Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
0.2410
-0.0110 (-4.37%)
Last updated: Nov 11, 2026, 10:48 AM CET
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €4.6 million as of November 11, 2026. It is the 44,715th most valuable company in the world and the 599th biggest in France. Its market cap has decreased by 49.66% in one year.
Market Cap
4.60M
Enterprise Value
8.14M
Revenue
1.80M
Global Rank
Country Rank
#599 France
PE Ratio
n/a
ChartMarket Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has decreased from 5.82M to 4.60M, a decrease of -21.05%. That is a compound annual growth rate of -5.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 4.60M | -38.42% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 17.61M |
| GenSight Biologics | 17.45M |
| Biophytis | 14.39M |
| Aelis Farma | 11.90M |
| TME Pharma | 10.01M |
| Advicenne | 9.47M |
| Poxel | 8.22M |
| Aton | 5.47M |